| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $91,286,035 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30HL176087 | The Role of Lymphatic Endothelial Cell- Expressed Sphingosine-1-Phosphate Receptor 1 on Immune Cell Trafficking and Response to Influenza Virus | 001 | 1 | NIH | 8/22/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30HL176087 | The Role of Lymphatic Endothelial Cell- Expressed Sphingosine-1-Phosphate Receptor 1 on Immune Cell Trafficking and Response to Influenza Virus | 000 | 1 | NIH | 8/22/2024 | $46,051 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 001 | 2 | NIH | 5/20/2024 | $28,976 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 2 | NIH | 1/19/2024 | $434,659 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI119048 | Differential Effects of TcdB1 and TcdB2 in C. difficile disease | 001 | 10 | NIH | 5/23/2024 | $43,230 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI119048 | Differential Effects of TcdB1 and TcdB2 in C. difficile disease | 000 | 10 | NIH | 1/11/2024 | $389,070 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 002 | 5 | NIH | 4/9/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 003 | 5 | NIH | 5/6/2024 | $214,963 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 001 | 5 | NIH | 1/25/2024 | $1,934,669 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 001 | 3 | NIH | 5/9/2024 | $24,726 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 3 | NIH | 12/5/2023 | $370,911 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 001 | 4 | NIH | 4/17/2024 | $16,585 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 4 | NIH | 12/8/2023 | $298,519 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K99AG088478 | Non-invasive brain stimulation and neurovascular mechanisms of post-stroke cognitive impairment | 000 | 1 | NIH | 8/1/2024 | $108,105 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 3 | NIH | 12/15/2023 | $379,983 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AA031280 | Efficacy of a Smartphone-based Just-in-Time Adaptive Intervention to ReduceDrinking among Adults Experiencing Homelessness | 000 | 1 | NIH | 8/20/2024 | $667,313 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | NU58DP007727 | Building Capacity for and Promoting Awareness of Evidence-based Prevention and Management of Chronic Venous Thromboembolism | 00 | 2 | CDC | 6/20/2024 | $374,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 2 | NIH | 3/5/2024 | $552,800 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 001 | 2 | NIH | 2/2/2024 | -$22,620 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 000 | 2 | NIH | 10/25/2023 | $36,513 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DE033289 | Understanding the role of PDGFRb signaling in Penttinen syndrome craniofacial development | 000 | 1 | NIH | 1/12/2024 | $35,738 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03AG079945 | Does age-dependent PFKFB3 down-regulation alter adipose tissue function | 000 | 2 | NIH | 12/1/2023 | $65,250 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q53063 | Geriatrics Workforce Enhancement Program | 01 | 1 | HRSA | 9/10/2024 | $1,742 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q53063 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $1,000,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 002 | 2 | NIH | 7/16/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03AG079945 | Does age-dependent PFKFB3 down-regulation alter adipose tissue function | 001 | 2 | NIH | 5/1/2024 | $7,250 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 001 | 2 | NIH | 6/18/2024 | $61,422 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI173108 | Understanding and leveraging immunometabolism to combat Clostridioides difficile infection | 000 | 2 | NIH | 7/5/2024 | $530,991 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T32AG052363 | GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA | 000 | 8 | NIH | 5/28/2024 | $335,203 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R34DA060534 | Developing An Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners | 000 | 1 | NIH | 9/6/2024 | $141,251 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R34DA060534 | Developing An Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners | 000 | 1 | NIH | 9/6/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI168175 | DNA sequence selectivity in conventional and aberrant V(D)J recombination | 000 | 2 | NIH | 7/17/2024 | $350,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI168175 | DNA sequence selectivity in conventional and aberrant V(D)J recombination | 000 | 2 | NIH | 7/17/2024 | $101,311 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA292973 | Role of JMJD4 in Pancreatic Cancer | 000 | 1 | NIH | 7/17/2024 | $145,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 001 | 4 | NIH | 3/21/2024 | $17,416 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI154274 | Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | 000 | 4 | NIH | 3/20/2024 | $397,764 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 001 | 3 | NIH | 4/23/2024 | $19,387 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 3 | NIH | 12/1/2023 | $59,566 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 000 | 5 | NIH | 11/15/2023 | $385,352 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 001 | 5 | NIH | 4/15/2024 | $21,411 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T03OH008614 | Great Plains Training for Industrial Hygiene Practice and Research | 00 | 21 | CDC | 7/16/2024 | $150,000 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21GM148901 | Development of large-scale sequence-function relationship using in situ optical sequencing | 002 | 3 | NIH | 8/26/2024 | $176,600 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA273168 | Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold | 002 | 3 | NIH | 8/7/2024 | $551,629 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA281135 | Improving Rates of Diagnostic Colonoscopy in Native Americans through a Culturally Sensitive Digital Outreach Intervention | 000 | 1 | NIH | 8/1/2024 | $397,045 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30CA225520 | D.R.I.V.E: Catalyzing Oncology Research Excellence and Enhancing Grant Writing Proficiency through Expert Mentorship | 006 | 7 | NIH | 4/18/2024 | $181,143 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30CA225520 | D.R.I.V.E: Catalyzing Oncology Research Excellence and Enhancing Grant Writing Proficiency through Expert Mentorship | 005 | 7 | NIH | 4/17/2024 | $2,034,508 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG080775 | Time restricted eating for prevention of age-related vascular cognitive decline in older adults | 001 | 2 | NIH | 7/10/2024 | $181,250 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01AG087810 | Tracking myeloid heterogeneity in mouse models and cerebrospinal fluid of HIV-suppressed individuals to classify neuroinflammation and identify molecular markers associated with clinical pathology | 000 | 1 | NIH | 8/9/2024 | $131,922 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30CA225520 | D.R.I.V.E: Catalyzing Oncology Research Excellence and Enhancing Grant Writing Proficiency through Expert Mentorship | 008 | 7 | NIH | 9/6/2024 | $197,241 |
|
